Vaccinex (VCNX) stock forecast for 2026
Last update: May 29, 2023 (07:45)
Sector: HealthcareThe share price of Vaccinex, Inc. (VCNX) now
50/200 Day Moving Average: $0.393 / $0.571
This figure corresponds to the Average Price over the previous 50/200 days. For Vaccinex stocks, the 50-day moving average is the resistance level today.
For Vaccinex stocks, the 200-day moving average is the resistance level today.
Are you interested in Vaccinex stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Vaccinex stock price in 2026. How much will one Vaccinex share be worth in 2026? Is it worth taking profit / loss on Vaccinex stock now or waiting? What are analysts' forecasts for Vaccinex stock?
We forecast Vaccinex stock performance using neural networks based on historical data on Vaccinex stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. The Vaccinex stock prediction results are shown below and presented as a graph, table and text information.
Vaccinex stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Vaccinex analysts is $7.
Today 200 Day Moving Average is the resistance level (0.571 $).
50 Day Moving Average is the resistance level (0.393 $).
Historical and forecast chart of Vaccinex stock
The chart below shows the historical price of Vaccinex stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Vaccinex stock price can be found in the table below.
Vaccinex (VCNX) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.64 | 0.60 | 0.69 | 13.26 % |
| Mar | 0.72 | 0.69 | 0.77 | 9.68 % |
| Mar | 0.73 | 0.65 | 0.75 | 13.91 % |
| Apr | 0.77 | 0.70 | 0.81 | 13.56 % |
| May | 0.79 | 0.73 | 0.88 | 16.64 % |
| Jun | 0.78 | 0.76 | 0.84 | 10.26 % |
| Jul | 0.86 | 0.83 | 0.90 | 6.99 % |
| Aug | 0.89 | 0.82 | 0.93 | 11.46 % |
| Sep | 0.89 | 0.84 | 0.93 | 9.65 % |
| Oct | 0.87 | 0.84 | 0.93 | 9.60 % |
| Nov | 0.88 | 0.78 | 0.97 | 19.54 % |
| Dec | 0.89 | 0.85 | 0.93 | 7.82 % |
Vaccinex information and performance
Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company’s product pipeline includes pepinemab (VX15), which targets Huntington’s Disease (HD) and non-small cell lung cancer (NSCLC) and also neurodegenerative disorders; VX5 Autoimmune for the treatment of MS and potentially for other autoimmune disorder; and others.
1895 MOUNT HOPE AVE, ROCHESTER, NY, US
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Vaccinex price target for 2026 by month
Target values for the price of one Vaccinex share for Jan 2026.
In Jan, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 13.259% volatility is expected.
Pessimistic target level: 0.60
Optimistic target level: 0.69
Target values for the price of one Vaccinex share for Mar 2026.
In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 9.682% volatility is expected.
Pessimistic target level: 0.69
Optimistic target level: 0.77
Target values for the price of one Vaccinex share for Mar 2026.
In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 13.914% volatility is expected.
Pessimistic target level: 0.65
Optimistic target level: 0.75
Target values for the price of one Vaccinex share for Apr 2026.
In Apr, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 13.559% volatility is expected.
Pessimistic target level: 0.70
Optimistic target level: 0.81
Target values for the price of one Vaccinex share for May 2026.
In May, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 16.640% volatility is expected.
Pessimistic target level: 0.73
Optimistic target level: 0.88
Target values for the price of one Vaccinex share for Jun 2026.
In Jun, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 10.256% volatility is expected.
Pessimistic target level: 0.76
Optimistic target level: 0.84
Target values for the price of one Vaccinex share for Jul 2026.
In Jul, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 6.987% volatility is expected.
Pessimistic target level: 0.83
Optimistic target level: 0.90
Target values for the price of one Vaccinex share for Aug 2026.
In Aug, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 11.462% volatility is expected.
Pessimistic target level: 0.82
Optimistic target level: 0.93
Target values for the price of one Vaccinex share for Sep 2026.
In Sep, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 9.648% volatility is expected.
Pessimistic target level: 0.84
Optimistic target level: 0.93
Target values for the price of one Vaccinex share for Oct 2026.
In Oct, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 9.602% volatility is expected.
Pessimistic target level: 0.84
Optimistic target level: 0.93
Target values for the price of one Vaccinex share for Nov 2026.
In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 19.539% volatility is expected.
Pessimistic target level: 0.78
Optimistic target level: 0.97
Target values for the price of one Vaccinex share for Dec 2026.
In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 7.824% volatility is expected.
Pessimistic target level: 0.85
Optimistic target level: 0.93